1. Home
  2. OTLK
  3. OTLK News

Latest Outlook Therapeutics Inc. (OTLK) News on September 7, 2024

Outlook Therapeutics® Announces Completion of Enrollment in NORSE EIGHT Clinical Trial
OTLK

GlobeNewswire

3 days ago

Outlook Therapeutics® Announces Completion of Enrollment in NORSE EIGHT Clinical Trial

Outlook Therapeutics® to Present at the H.C. Wainwright 26th Annual Global Investment Conference
OTLK

GlobeNewswire

4 days ago

Outlook Therapeutics® to Present at the H.C. Wainwright 26th Annual Global Investment Conference

OTLK

Thomson Reuters StreetEvents

24 days ago

Q3 2024 Outlook Therapeutics Inc Earnings Call

Outlook Therapeutics® Reports Financial Results for Third Quarter Fiscal Year 2024 and Provides Corporate Update
OTLK

GlobeNewswire

25 days ago

Outlook Therapeutics® Reports Financial Results for Third Quarter Fiscal Year 2024 and Provides Corporate Update

Outlook Therapeutics® to Present at the H.C. Wainwright 4th Annual Ophthalmology Virtual Conference
OTLK

GlobeNewswire

a month ago

Outlook Therapeutics® to Present at the H.C. Wainwright 4th Annual Ophthalmology Virtual Conference

Why Is Caligan Partners Bullish on Outlook Therapeutics Inc (OTLK) Right Now?
OTLK

Insider Monkey

a month ago

Why Is Caligan Partners Bullish on Outlook Therapeutics Inc (OTLK) Right Now?

Outlook Therapeutics® to Report Financial Results for Third Quarter Fiscal Year 2024 on August 14, 2024 and Host Quarterly Conference Call and Webcast
OTLK

GlobeNewswire

a month ago

Outlook Therapeutics® to Report Financial Results for Third Quarter Fiscal Year 2024 on August 14, 2024 and Host Quarterly Conference Call and Webcast

Outlook Therapeutics® to Present at the BTIG Virtual Biotechnology Conference 2024
OTLK

GlobeNewswire

a month ago

Outlook Therapeutics® to Present at the BTIG Virtual Biotechnology Conference 2024

OTLK

MT Newswires

2 months ago

Outlook Therapeutics Receives UK Marketing Authorization for Eye Disease Drug

Outlook Therapeutics® Announces UK MHRA Marketing Authorization of LYTENAVA™ (bevacizumab gamma) for the Treatment of Wet AMD
OTLK

GlobeNewswire

2 months ago

Outlook Therapeutics® Announces UK MHRA Marketing Authorization of LYTENAVA™ (bevacizumab gamma) for the Treatment of Wet AMD

Outlook Therapeutics, Inc.'s (NASDAQ:OTLK) largest shareholders are individual investors with 31% ownership, private equity firms own 31%
OTLK

Simply Wall St.

3 months ago

Outlook Therapeutics, Inc.'s (NASDAQ:OTLK) largest shareholders are individual investors with 31% ownership, private equity firms own 31%

Outlook Therapeutics® to Present at the Virtual Investor Pitch Conference
OTLK

GlobeNewswire

3 months ago

Outlook Therapeutics® to Present at the Virtual Investor Pitch Conference

OTLK

MT Newswires

3 months ago

Outlook Therapeutics Granted EU Marketing Authorization for Lytenava to Treat Wet AMD

Outlook Therapeutics® Receives European Commission Marketing Authorization for LYTENAVA™ (bevacizumab gamma) for the Treatment of Wet AMD
OTLK

GlobeNewswire

3 months ago

Outlook Therapeutics® Receives European Commission Marketing Authorization for LYTENAVA™ (bevacizumab gamma) for the Treatment of Wet AMD

OTLK

Thomson Reuters StreetEvents

4 months ago

Q2 2024 Outlook Therapeutics Inc Earnings Call

Outlook Therapeutics® Reports Financial Results for Second Quarter Fiscal Year 2024 and Provides Corporate Update
OTLK

GlobeNewswire

4 months ago

Outlook Therapeutics® Reports Financial Results for Second Quarter Fiscal Year 2024 and Provides Corporate Update

OTLK

MT Newswires

4 months ago

Outlook Therapeutics Submits Marketing Application for Wet Age-related Macular Degeneration Therapy in UK

Outlook Therapeutics® Announces UK Submission of Marketing Authorization Application (MAA) for ONS-5010 as a Treatment for Wet AMD
OTLK

GlobeNewswire

4 months ago

Outlook Therapeutics® Announces UK Submission of Marketing Authorization Application (MAA) for ONS-5010 as a Treatment for Wet AMD

Outlook Therapeutics® to Report Financial Results for Second Quarter Fiscal Year 2024 on May 16, 2024 and Host Inaugural Quarterly Conference Call and Webcast
OTLK

GlobeNewswire

4 months ago

Outlook Therapeutics® to Report Financial Results for Second Quarter Fiscal Year 2024 on May 16, 2024 and Host Inaugural Quarterly Conference Call and Webcast

Outlook Therapeutics® to Present at the Retina World Congress 2024
OTLK

GlobeNewswire

4 months ago

Outlook Therapeutics® to Present at the Retina World Congress 2024

Outlook Therapeutics® to Present at the Ophthalmology Innovation Summit (OIS) Retina Innovation Showcase
OTLK

GlobeNewswire

4 months ago

Outlook Therapeutics® to Present at the Ophthalmology Innovation Summit (OIS) Retina Innovation Showcase

Marriott Vacations, Carrols Restaurant Group, and More Stocks See Action From Activist Investors
OTLK

Barrons.com

4 months ago

Marriott Vacations, Carrols Restaurant Group, and More Stocks See Action From Activist Investors

Outlook Therapeutics® Announces Closing of Private Placement of $5.0 Million
OTLK

GlobeNewswire

5 months ago

Outlook Therapeutics® Announces Closing of Private Placement of $5.0 Million

Insiders are Piling into These 10 Healthcare Stocks in 2024
OTLK

Insider Monkey

5 months ago

Insiders are Piling into These 10 Healthcare Stocks in 2024

Outlook Therapeutics® Receives European Union Positive CHMP Opinion for ONS-5010 as a Treatment for Wet AMD
OTLK

GlobeNewswire

6 months ago

Outlook Therapeutics® Receives European Union Positive CHMP Opinion for ONS-5010 as a Treatment for Wet AMD

Outlook Therapeutics® Announces Closing of Private Placement of up to $159 Million
OTLK

GlobeNewswire

6 months ago

Outlook Therapeutics® Announces Closing of Private Placement of up to $159 Million

Outlook Therapeutics® Announces Effective Date for 1-for-20 Reverse Stock Split
OTLK

GlobeNewswire

6 months ago

Outlook Therapeutics® Announces Effective Date for 1-for-20 Reverse Stock Split

7 of the Best Speculative Stocks You Can Snag for Less Than $1
OTLK

InvestorPlace

6 months ago

7 of the Best Speculative Stocks You Can Snag for Less Than $1

7 Biotech Penny Stocks on the Verge of Clinical Trial Victory
OTLK

InvestorPlace

6 months ago

7 Biotech Penny Stocks on the Verge of Clinical Trial Victory

OTLK

GuruFocus.com

7 months ago

Outlook Therapeutics Inc (OTLK) Reports Q1 Fiscal 2024 Results and Strategic Developments

Outlook Therapeutics® Reports Financial Results for First Quarter Fiscal Year 2024 and Provides Corporate Update
OTLK

GlobeNewswire

7 months ago

Outlook Therapeutics® Reports Financial Results for First Quarter Fiscal Year 2024 and Provides Corporate Update

Eos Energy Enterprises Join Forces with SABIC Specialties to Produce a Specialty Light-Weight, Conductive Composite Thermoplastic for Eos Z3TM Battery
OTLK

GlobeNewswire

7 months ago

Eos Energy Enterprises Join Forces with SABIC Specialties to Produce a Specialty Light-Weight, Conductive Composite Thermoplastic for Eos Z3TM Battery

Outlook Therapeutics® Doses First Subject in NORSE EIGHT
OTLK

GlobeNewswire

7 months ago

Outlook Therapeutics® Doses First Subject in NORSE EIGHT

Powerfleet and MiX Telematics Announce Shareholders Meetings to Vote on Proposed Business Combination
OTLK

PR Newswire

7 months ago

Powerfleet and MiX Telematics Announce Shareholders Meetings to Vote on Proposed Business Combination

Here's What We Like About Peoples Bancorp of North Carolina's (NASDAQ:PEBK) Upcoming Dividend
OTLK

Simply Wall St.

7 months ago

Here's What We Like About Peoples Bancorp of North Carolina's (NASDAQ:PEBK) Upcoming Dividend

HYZON DELIVERS FIRST FOUR FUEL CELL ELECTRIC VEHICLES TO PERFORMANCE FOOD GROUP
OTLK

PR Newswire

7 months ago

HYZON DELIVERS FIRST FOUR FUEL CELL ELECTRIC VEHICLES TO PERFORMANCE FOOD GROUP

OTLK

Associated Press Finance

7 months ago

Alerus: Q4 Earnings Snapshot

Alerus Financial Corp (ALRS) Reports Q4 Loss and Balance Sheet Repositioning
OTLK

GuruFocus.com

7 months ago

Alerus Financial Corp (ALRS) Reports Q4 Loss and Balance Sheet Repositioning

Alerus Financial Corporation Announces Fourth Quarter 2023 Results, Including Balance Sheet Repositioning
OTLK

Business Wire

7 months ago

Alerus Financial Corporation Announces Fourth Quarter 2023 Results, Including Balance Sheet Repositioning

Outlook (OTLK) Surges 31% on Regulatory Update for AMD Study
OTLK

Zacks

7 months ago

Outlook (OTLK) Surges 31% on Regulatory Update for AMD Study

Aemetis Biogas Expands Revenues with First Sale of Low Carbon Fuel Standard Credits
OTLK

NewMediaWire

7 months ago

Aemetis Biogas Expands Revenues with First Sale of Low Carbon Fuel Standard Credits

Outlook Therapeutics® Receives FDA Agreement Under Special Protocol Assessment (SPA) for 90 Day Non-Inferiority Study, NORSE EIGHT, and Announces Private Placement of Up to $172 Million to Advance ONS-5010
OTLK

GlobeNewswire

7 months ago

Outlook Therapeutics® Receives FDA Agreement Under Special Protocol Assessment (SPA) for 90 Day Non-Inferiority Study, NORSE EIGHT, and Announces Private Placement of Up to $172 Million to Advance ONS-5010

Hear from Ciaran Long, CFO of a.k.a. Brands Live at ICR Conference 2024
OTLK

IPO-Edge.com

8 months ago

Hear from Ciaran Long, CFO of a.k.a. Brands Live at ICR Conference 2024

FirstSun, HomeStreet to merge
OTLK

Banking Dive

8 months ago

FirstSun, HomeStreet to merge

HomeStreet to sell itself after tough year
OTLK

American Banker

8 months ago

HomeStreet to sell itself after tough year

Armada Hoffler To Discuss Fourth Quarter Earnings On February 22nd
OTLK

GlobeNewswire

8 months ago

Armada Hoffler To Discuss Fourth Quarter Earnings On February 22nd

LuxUrban Hotels to Present at Upcoming Investor Conferences
OTLK

Business Wire

8 months ago

LuxUrban Hotels to Present at Upcoming Investor Conferences

The 3 Best Biotech Stocks to Buy in January 2024
OTLK

InvestorPlace

8 months ago

The 3 Best Biotech Stocks to Buy in January 2024

SKYX Will Debut Its New Patented Game-Changing Smart Home Platforms Technologies at CES 2024 - Opening Today, January 9th in Las Vegas
OTLK

ACCESSWIRE

8 months ago

SKYX Will Debut Its New Patented Game-Changing Smart Home Platforms Technologies at CES 2024 - Opening Today, January 9th in Las Vegas

Qurate CEO Talks Turnaround and Growth Plans
OTLK

WWD

8 months ago

Qurate CEO Talks Turnaround and Growth Plans

VIZSLA SILVER ANNOUNCES SIGNIFICANT INCREASE IN CONTAINED OUNCES AND INCREASE IN GRADE OF INDICATED CATEGORY TO 551 G/T AGEQ IN UPDATED MINERAL RESOURCES ESTIMATE
OTLK

CNW Group

8 months ago

VIZSLA SILVER ANNOUNCES SIGNIFICANT INCREASE IN CONTAINED OUNCES AND INCREASE IN GRADE OF INDICATED CATEGORY TO 551 G/T AGEQ IN UPDATED MINERAL RESOURCES ESTIMATE

Reviva Provides Corporate and Program Updates and Highlights Key Upcoming Milestones
OTLK

GlobeNewswire

8 months ago

Reviva Provides Corporate and Program Updates and Highlights Key Upcoming Milestones

Alimera Completes Recruitment for the Synchronicity Study
OTLK

GlobeNewswire

8 months ago

Alimera Completes Recruitment for the Synchronicity Study

Relmada Therapeutics Provides Corporate Update
OTLK

PR Newswire

8 months ago

Relmada Therapeutics Provides Corporate Update

Novartis Sweetens Its Deal With Voyager, And VYGR Stock Flashes A Bullish Sign
OTLK

Investor's Business Daily

8 months ago

Novartis Sweetens Its Deal With Voyager, And VYGR Stock Flashes A Bullish Sign

Outlook Therapeutics® Reports Financial Results for Fiscal Year 2023 and Reiterates ONS-5010 Clinical and Regulatory Path Forward in the U.S. and EU
OTLK

GlobeNewswire

9 months ago

Outlook Therapeutics® Reports Financial Results for Fiscal Year 2023 and Reiterates ONS-5010 Clinical and Regulatory Path Forward in the U.S. and EU

Verint Systems Inc Chairman & CEO Dan Bodner Sells 13,171 Shares
OTLK

GuruFocus.com

9 months ago

Verint Systems Inc Chairman & CEO Dan Bodner Sells 13,171 Shares

Verint Open CCaaS Platform Named Best Customer Engagement Solution in UC Today Partner Awards
OTLK

Business Wire

9 months ago

Verint Open CCaaS Platform Named Best Customer Engagement Solution in UC Today Partner Awards

Outlook Therapeutics® Submits Special Protocol Assessment (SPA) to FDA for Non-Inferiority Study of ONS-5010
OTLK

GlobeNewswire

9 months ago

Outlook Therapeutics® Submits Special Protocol Assessment (SPA) to FDA for Non-Inferiority Study of ONS-5010

Eos Energy Announces Launch of Proposed $40M Public Offering
OTLK

GlobeNewswire

9 months ago

Eos Energy Announces Launch of Proposed $40M Public Offering

SOPHiA GENETICS to Present at the J.P. Morgan 2024 Healthcare Conference
OTLK

GlobeNewswire

9 months ago

SOPHiA GENETICS to Present at the J.P. Morgan 2024 Healthcare Conference

Eos Energy and Pine Gate Renewables Announce Partnership Expansion
OTLK

GlobeNewswire

9 months ago

Eos Energy and Pine Gate Renewables Announce Partnership Expansion

OTLK

PR Newswire

9 months ago

THE SWISS HELVETIA FUND, INC. DECLARES QUARTERLY DISTRIBUTION AT NEW RATE OF $0.129 PER SHARE

Forrester Opens Nominations For Its 2024 Customer Obsession Awards
OTLK

PR Newswire

9 months ago

Forrester Opens Nominations For Its 2024 Customer Obsession Awards

Wall Street Analysts Believe Caribou Biosciences, Inc. (CRBU) Could Rally 285.29%: Here's is How to Trade
OTLK

Zacks

9 months ago

Wall Street Analysts Believe Caribou Biosciences, Inc. (CRBU) Could Rally 285.29%: Here's is How to Trade

Outlook Therapeutics® Announces Strategic Organizational Realignment
OTLK

GlobeNewswire

9 months ago

Outlook Therapeutics® Announces Strategic Organizational Realignment

Forrester: European Retail Sales To Reach €2.7 Trillion By 2028
OTLK

Business Wire

9 months ago

Forrester: European Retail Sales To Reach €2.7 Trillion By 2028

OTLK

Business Wire

9 months ago

Energy Vault Receives Successful Technical Due Diligence Evaluation for the Bankability of B-VAULT™ Battery Energy Storage System from Global Authority DNV

OTLK

Business Wire

9 months ago

Energy Vault Announces Participation at the Shareholder Equity Conference

Adaptimmune Receives Transfer of IND for Lete-cel Program
OTLK

Newsfile

9 months ago

Adaptimmune Receives Transfer of IND for Lete-cel Program

Loss-Making Outlook Therapeutics, Inc. (NASDAQ:OTLK) Expected To Breakeven In The Medium-Term
OTLK

Simply Wall St.

9 months ago

Loss-Making Outlook Therapeutics, Inc. (NASDAQ:OTLK) Expected To Breakeven In The Medium-Term

Outlook Therapeutics® Announces Receipt of Type A Meeting Minutes and Reiterates Regulatory Path Forward for ONS-5010
OTLK

GlobeNewswire

9 months ago

Outlook Therapeutics® Announces Receipt of Type A Meeting Minutes and Reiterates Regulatory Path Forward for ONS-5010

First Guaranty Bancshares (NASDAQ:FGBI) Is Due To Pay A Dividend Of $0.16
OTLK

Simply Wall St.

9 months ago

First Guaranty Bancshares (NASDAQ:FGBI) Is Due To Pay A Dividend Of $0.16

Baozun (BZUN) Q3 2023 Earnings Call Transcript
OTLK

Motley Fool

10 months ago

Baozun (BZUN) Q3 2023 Earnings Call Transcript

Is Viemed Healthcare, Inc. (TSE:VMD) Trading At A 50% Discount?
OTLK

Simply Wall St.

10 months ago

Is Viemed Healthcare, Inc. (TSE:VMD) Trading At A 50% Discount?

OTLK

Business Wire

10 months ago

Energy Vault Holdings, Inc. Announces Inducement Grants Under NYSE Listing Rule 303A.08

25 Highest Quality Furniture Brands in the World
OTLK

Insider Monkey

10 months ago

25 Highest Quality Furniture Brands in the World

OTLK

Business Wire

10 months ago

ADTRAN Holdings, Inc. to Meet with Investors at the Deutsches Eigenkapitalforum 2023 on November 27-28, 2023

Ellsworth Growth and Income Fund Ltd. Declares Distribution of $0.13 Per Share
OTLK

GlobeNewswire

10 months ago

Ellsworth Growth and Income Fund Ltd. Declares Distribution of $0.13 Per Share

Adtran integrates Intel NetSec Accelerator Reference Design with Ensemble Cloudlet to enable edge cluster nodes and deliver edge cloud performance
OTLK

Business Wire

10 months ago

Adtran integrates Intel NetSec Accelerator Reference Design with Ensemble Cloudlet to enable edge cluster nodes and deliver edge cloud performance

Inogen Announces Leadership Change with the Appointment of Kevin Smith as President and CEO
OTLK

Business Wire

10 months ago

Inogen Announces Leadership Change with the Appointment of Kevin Smith as President and CEO

InnovAge Holding Corp. (INNV) Reports Q1 Loss, Tops Revenue Estimates
OTLK

Zacks

10 months ago

InnovAge Holding Corp. (INNV) Reports Q1 Loss, Tops Revenue Estimates

OTLK

Business Wire

10 months ago

Energy Vault Reports Third Quarter 2023 Financial Results

RumbleON Inc (RMBL) Reports Q3 2023 Financial Results: Net Loss of $16.5 Million
OTLK

GuruFocus.com

10 months ago

RumbleON Inc (RMBL) Reports Q3 2023 Financial Results: Net Loss of $16.5 Million

Energy Vault, Wellhead and W Power Begin Commercial Operations of Stanton Battery Energy Storage System
OTLK

Business Wire

10 months ago

Energy Vault, Wellhead and W Power Begin Commercial Operations of Stanton Battery Energy Storage System

Citizens, Inc. Reports Third Quarter 2023 Financial Results
OTLK

Newsfile

10 months ago

Citizens, Inc. Reports Third Quarter 2023 Financial Results

Share on Social Networks: